Nerve growth factor-induced differentiation does not alter the biochemical properties of a mutant prion protein expressed in PC12 cells

Journal of Neurochemistry

Volumn 75, Issue 1, 2000, Pages 72-80

  Chiesa, Roberto ^a   Harris, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mutation; Nerve growth factor; PC12 cells; Prion; Scrapie

Indexed keywords

NERVE GROWTH FACTOR; PHOSPHOLIPASE; PRION PROTEIN; PROTEINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MUTANT; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT;

ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURVIVAL; GENE EXPRESSION; GLYCOSYLPHOSPHATIDYLINOSITOLS; MICE; MUTAGENESIS; NERVE GROWTH FACTOR; PC12 CELLS; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PRIONS; RATS; TRANSFECTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0034100067     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750072.x     Document Type: Article

References (40)

1. Bolton D. C., Seliginan S. J., Bablanian G., Windsor D., Scala L. J., Kim K. S., Chen C. M., Kascsak R. J., and Bendheim P. E. (1991) Molecular location of a species-specific epitope on the hamster scrapie agent protein. J. Virol. 65, 3667-3675.
2. Borchelt D. R., Rogers M., Stahl N., Telling G., and Prusiner S. B. (1993) Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3, 319-329.
3. Brown D. R. (1999) Prion protein peptide neurotoxicity can be mediated by astrocytes. J. Neurochem. 73, 1105-1113.
4. Butler D. A., Scott M. R. D., Bockman J. M., Borchelt D. R., Taraboulos A., Hsiao K. K., Kingsbury D. T., and Prusiner S. B. (1988) Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 62, 1558-1564.
5. Chiesa R., Piccardo P., Ghetti B., and Harris D. A. (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21, 1339-1351.
6. Chiesa R., Drisaldi B., Quaglio E., Migheli A., Piccardo P., Ghetti B., and Harris D. A. (2000) Accumulation of protease-resistant PrP and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc. Natl. Acad. Sci. USA (in press).
7. Daude N., Lehmann S., and Harris D. A. (1997) Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J. Biol. Chem. 272, 11604-11612.
8. Duchen L. W., Poulter M., and Harding A. E. (1993) Dementia associated with a 216 base pair insertion in the prion protein gene: clinical and neuropathological features. Brain 116, 555-567.
9. Gambetti P., Petersen R. B., Parchi P., Chen S. G., Capellari S., Goldfarb L., Gabizon R., Montagna P., Lugaresi E., Piccardo P., and Ghetti B. (1999) Inherited prion diseases, in Prion Biology and Diseases (Prusiner S. B., ed), pp. 509-583. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
10. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
11. Greene L. A., Sobeih M. M., and Teng K. K. (1991) Methodologies for the culture and experimental use of the PC12 rat pheochromocytoma cell line, in Culturing Nerve Cells (Banker G. and Goslin K., eds), pp. 207-226. MIT Press, Cambridge.
12. Harris D. A., Huber M. T., van Dijken P., Shyng S.-L., Chait B. T., and Wang R. (1993) Processing of a cellular prion protein: identification of N-and C-terminal cleavage sites. Biochemistry 32, 1009-1016.
13. Ilangumaran S., Robinson P. J., and Hoessli D. C. (1996) Transfer of exogenous glycosylphosphatidylinositol (GPI)-linked molecules to plasma membranes. Trends Cell Biol. 6, 163-167.
14. Kascsak R. J., Rubinstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., and Diringer H. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61, 3688-3693.
15. Krasemann S., Zerr I., Weber T., Poser S., Kretzschmar H., Hunsmann G., and Bodemer W. (1995) Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene. Mol. Brain Res. 34, 173-176.
16. Kristensson K., Feuerstein B., Taraboulos A., Hyun W. C., Prusiner S. B., and DeArmond S. J. (1993) Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology 43, 2335-2341.
17. Lehmann S. and Harris D. A. (1995) A mutant prion protein displays an aberrant membrane association when expressed in cultured cells. J. Biol. Chem. 270, 24589-24597.
18. Lehmann S. and Harris D. A. (1996a) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol. Chem. 271, 1633-1637.
19. Lehmann S. and Harris D. A. (1996b) Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc. Natl. Acad. Sci. USA 93, 5610-5614.
20. Lehmann S. and Harris D. A. (2000) A mutant prion protein displays an aberrant membrane association when expressed in cultured cells [Correction]. J. Biol. Chem. 275, 1520.
21. Mangé A., Milhavet O., McMahon H. E., Casanova D., and Lehmann S. (2000) Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies. J. Neurochem. 74, 754-762.
22. Mesner P. W., Winters T. R., and Green S. H. (1992) Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119, 1669-1680.
23. Milhavet O., Mangé A., Casanova D., and Lehmann S. (2000) Effect of Congo red on wild-type and mutated prion proteins in cultured cells. J. Neurochem. 74, 222-230.
24. Narwa R. and Harris D. A. (1999) Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors. Biochemistry 38, 8770-8777.
25. Owen F., Poulter M., Collinge J., Leach M., Lofthouse R., Crow T. J., and Harding A. E. (1992) A dementing illness associated with a novel insertion in the prion protein gene. Mol. Brain Res. 13, 155-157.
26. Petersen R. B., Parchi P., Richardson S. L., Urig C. B., and Gambetti P. (1996) Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J. Biol. Chem. 271, 12661-12668.
27. Priola S. A. and Chesebro B. (1998) Abnormal properties of prion protein with insertional mutations in different cell types. J. Biol. Chem. 273, 11980-11985.
28. Prusiner S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
29. Race R. E., Caughey B., Graham K., Ernst D., and Chesebro B. (1988) Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J. Virol. 62, 2845-2849.
30. Rubinstein R., Deng H., Scalici C. L., and Papini M. C. (1991) Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. J. Gen. Virol. 72, 1279-1285.
31. Schätzl H. M., Laszlo L., Holtzman D. M., Tatzelt J., DeArmond S. J., Weiner R. I., Mobley W. C. and Prusiner S. B. (1997) A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71, 8821-8831.
32. Schubert D., Humphreys S., Jacob F., and De Vitry F. (1971) Induced differentiation of a neuroblastoma. Dev. Biol. 25, 514-546.
33. Shyng S. L., Moulder K. L., Lesko A., and Harris D. A. (1995) The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J. Biol. Chem. 270, 14793-14800.
34. Singh N., Zanusso G., Chen S. G., Fujioka H., Richardson S., Gambetti P., and Petersen R. B. (1997) Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J. Biol. Chem. 272, 28461-28470.
35. Stahl N., Baldwin M. A., Hecker R., Pan K.-M., Burlingame A. L., and Prusiner S. B. (1992) Glycosylinositol phospholipid anchors of the scrapie and cellular prion proteins contain sialic acid. Biochemistry 31, 5043-5053.
36. Taraboulos A., Serban D., and Prusiner S. B. (1990) Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J. Cell Biol. 110, 2117-2132.
37. Ulrich M. J. and Ley T. J. (1990) Function of normal and mutated γ-globin gene promoters in electroporated K562-erythroleukemia cells. Blood 75, 990-999.
38. 3 release. Neurology 47, 741-750.
39. Young K., Piccardo P., Dlouhy S., Bugiani O., Tagliavini F., and Ghetti B. (1999) The human genetic prion diseases, in Prions: Molecular and Cellular Biology (Harris D. A., ed), pp. 139-175. Horizon Scientific Press, Wymondham.
40. Zanusso G., Petersen R. B., Jin T., Jing Y., Kanoush R., Ferrari S., Gambetti P., and Singh N. (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem. 274, 23396-23404.